AG

Anjani Ganesan Iyer

Active Director Director DIN 00322633
DIN 00322633 First appointment Sep 1986 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 1986
Shareholding value •••• Premium profile

About Anjani Ganesan Iyer

Data last updated:

Anjani Ganesan Iyer is a Director at Karnil Pharma Pvt Ltd (since 1986). The company operates in Chemicals. Karnil Pharma Pvt Ltd reported revenue of ₹43.9 Lakh (FY 2025).

DIN 00322633
Primary Designation Director
Industry Chemicals
First Appointment 08 Sep 1986
Oldest Company Age 40 yrs
Largest company Karnil Pharma Pvt Ltd · ₹43.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Karnil Pharma Pvt Ltd U24232MH1986PTC040851
Director08 Sep 19861986₹43.9 Lakh (FY 2025)Active

Board colleagues of Anjani Ganesan Iyer

NameDINCompanyDesignation
Ganesan Sundaresan Iyer00322510Karnil Pharma Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Karnil Pharma Pvt Ltd
Premium access

Shareholding and investment profile for Anjani Ganesan Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjani Ganesan Iyer

Anjani Ganesan Iyer currently holds 1 directorship: Karnil Pharma Pvt Ltd (Director, since 08 Sep 1986, revenue ₹43.9 Lakh (FY 2025)).

Anjani Ganesan Iyer was first appointed on 08 Sep 1986 as Director at Karnil Pharma Pvt Ltd.

The current boards of Anjani Ganesan Iyer's companies include Ganesan Sundaresan Iyer (Karnil Pharma Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available